Real-World Screening Data for Liver Fibrosis in Psoriasis Patients Treated with Biologics

• DOI: 10.1272/jnms.jnms.2024_91-613
• Publication Date: 2024-12-26T22:15:41Z
• Authors: Susumu Ichiyama; Michiko Ito; Saeko Ozaki; Taeang Arai; Masanori Atsukawa; Katsuhiko Iwakiri; Teppei Hagino; Toshihiko Hoashi; Naoko Kanda; Hidehisa Saeki

Metabolic dysfunction-associated steatotic liver disease (MASLD) is positively associated with the prevalence and severity of psoriasis. The fibrosis-4 (FIB-4) index was developed to predict significant fibrosis. Using FIB-4 index, present study evaluated screening data for fibrosis, including MASLD, in patients refractory psoriasis treated biologics.